Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, June 23, 2019

The Novel Methodology and Training Units of the Biostatistics and Epidemiology Research Design (BERD) Key

Component Activity of the Oklahoma Shared Clinical and Translational Resources (OSCTR) are hosting a training


The workshop series is scheduled for June 26-28, 2019 from noon-2 p.m.

If you would like to attend the workshops, please complete the following registration form:

For additional information see the attached document.



OUHSC Announces an Industry-Sponsored Clinical Trials Facilities & Administration Rate Increase

(effective immediately) – refer to attached letter from the Provost.



Harold Hamm Diabetes Center (HHDC) - Please mark your calendar for the 16th Annual Harold Hamm

Diabetes Center Research Symposium.  This event will be held on Friday, November 15, 2019 at the

Samis Education Center at Children’s Hospital in Oklahoma City. Deadline for abstracts will be announced

later this summer.  Additional details will be posted on  Questions?  Please email





Notice to Allow Requests for Budget Increases for NINDS Research Program Award (R35) (NOT-NS-19-058)


NIH Expanding Usage of Notices of Special Interest (NOT-OD-19-107)


Request for Information (RFI): Guidance on Current Clinical Experience in the Use of Telemental Health for Suicide

Prevention in Emergency Department Settings (NOT-MH-19-030)


Notice of Clarification to RFA-CA-19-032, "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection

(R01 Clinical Trial Optional)" (NOT-CA-19-053)


Notice of Intent to Publish a Funding Opportunity Announcement for Utilizing Invasive Recording and Stimulating

Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (NOT-MH-20-022)


Notice of Intent to Publish a Funding Opportunity Announcement for NIH Blueprint for Neuroscience Research

Education Program on Translational Devices (R25) (NOT-NS-19-068)



Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.




Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) (PAR-19-297) – Deadline October 5, 2019


Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) (PAR-19-298) - Deadline
October 5, 2019.


Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed)

(RFA-AG-20-007) – Deadline October 22, 2019


Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional) (RFA-AG-20-022) - Deadline
October 22, 2019


Undergraduate Research Education Program (UP) to Enhance Diversity in the Environmental Health Sciences

(R25 Clinical Trial Not Allowed) (RFA-ES-19-010) – Deadline August 30, 2019


Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders (U24 Clinical Trial Not

Allowed) (RFA-MH-20-215) – Deadline August 16, 2019


Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia

(VCID)(R01 Clinical Trial Not Allowed) (RFA-NS-19-039) – Deadline August 14, 2019


"Clinical Trials" on a Chip: Tissue Chips to Inform Clinical Trial Design and Implementation in Precision Medicine

(UG3/UH3 - Clinical Trial Not Allowed) (RFA-TR-19-014) - Deadline October 9, 2019





American Diabetes Association (ADA) – Pathway Program – Deadline July 1, 2019


ADA – Core Program – Deadline July 15, 2019


Pfiizer Global Medical Grants – 2019 Global Breast Cancer Competitive Grant Research Program

Letter of Intent due October 15, 2019


Pfizer Advance – Global Awards for Advancing Chronic Pain Research – Deadline August 8, 2019


Pfizer – 2019 Global Hemophilia ASPIRE Competitive Grant Program – Deadline August 31, 2019


Pfizer – Improving Duration of Therapy and Outcomes in NSCLC Patients Receiving Targeted Therapy

Letter of Intent due June 24, 2019